TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 7, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 2
- 0 vs. Q4 2025
- Portfolio value
- $266.9M
- +$11.8M (+4.6%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | COM | 4,473,958 | $133.5M | 50.0% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 6,374,574 | $133.4M | 50.0% | −1,500,000−19.0% | Reduced | History |